Mirae Asset Global Etfs Holdings Ltd. Prothena Corp Public LTD CO Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,718 shares of PRTA stock, worth $382,683. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,718
Previous 24,804
3.68%
Holding current value
$382,683
Previous $511,000
15.85%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$172 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$62.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$57.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$56.9 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25.9 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $698M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...